期刊文献+

体重指数与慢性阻塞性肺疾病及生活质量的关系 被引量:82

A study on the correlation of body mass index with chronic obstructive pulmonary disease and quality of life
原文传递
导出
摘要 目的在2002至2004年中国7个地区(北京、上海、广东、辽宁、天津、重庆和陕西)慢性阻塞性肺疾病(COPD)现况调查的基础上,探讨体重指数(BMI)与 COPD 的关系。方法现况调查采用多阶段分层整群随机抽样方法,对40岁及以上的居民进行问卷调查、身高和体重的测量及肺功能检测。调查有效人数为20245名,男8705名,女11540名,以支气管扩张试验后第一秒用力呼气容积/用力肺活量(FEV_1/FVC)<70%作为 COPD 的诊断标准,并排除其他已知的气流受限的疾病,共筛查出1668例 COPD 和18577例非 COPD 进行 BMI 与 COPD 的关系分析。结果 COPD 患者的BMI[(22.7±3.5)kg/m^2]较非 COPD 患者[(24.1±3.4)kg/m^2]低,吸烟者 BMI 为[(23.6±3.4)kg/m^2]较不吸烟者[(24.2±3.5)kg/m^2]低,差异均有统计学意义(F 分别为158.31、49.10,P 均<0.01),且 COPD 与吸烟存在对 BMI 的交互作用(F=6.03,P<0.05)。COPD 病情程度分级越高 BMI越低(F=45.46,P<0.01),COPD 病情程度分级与 BMI 分级存在负相关(r=-0.08,P<0.01)。BMI 越低 COPD 的患病率越高(趋势 X^2=102.68,P<0.01),多因素 logistic 回归分析显示,与正常BMI(18.5~23.9 kg/m^2)比较,1级 BMI(<18.5 kg/m^2)、3级 BMI(24.0~27.9 kg/m^2)和4级 BMI(≥28.0 kg/m^2)患 COPD 的 OR 值分别为[2.12(1.73~2.59)、0.67(0.59~0.76)、0.60(0.49~0.73),P 均<0.05];且 BMI 分级与吸烟存在对 COPD 的交互作用(X^2=4.73,P<0.05)。与2级 BMI的 COPD 患者比较,1级 BMI 的 COPD 患者生活质量差(心理指数评分:55±8、57±6,F=2.96,P<0.05;躯体指数评分:42±10、46±9,F=4.21,P<0.01);气促分数高(1.4±1.5、1.1±1.3,X^2=14.32,P<0.01)。结论 1级 BMI 与 COPD 关系密切,其可能是 COPD 患病的独立于吸烟的危险因素,而低 BMI 也可能是 COPD 病情严重程度的一个重要指标。 Objective To investigate the correlation between body mass index (BMI) and chronic obstructive pulmonary disease (COPD) , based on a cross-sectional COPD survey conducted in Beijing, Shanghai, Guangdong, Liaoning, Tianjin, Cbengqing and Shaanxi of China between 2002-2004. Methods A multi-stage stratification cluster sampling strategy was used in this cross-sectional survey, and 2 0245 subjects (8705 males and 11 540 females) aged 40 years or older were recruited, interviewed with a questionnaire, measured for height and weight, and tested with spirometry. 1668 subjects with postbronchodilator FEV1/FVC less than 70% were identified as having COPD after other known causes of airflow limitation were excluded. Analysis on relationship between COPD and BMI was performed in 1668 COPD and 18 577 non-COPD subjects. Resulls Compared with non-COPD subjects, BMI was significantly lower in COPDpatients [(22.7 ±3.5) vs (24. 1±3.4) kg/m^2, F= 158. 31, P 〈0.01]; BMI was also significantly lower in smokers than in non-smokers [ ( 23.6 ± 3.4 ) vs ( 24.2 ± 3.5 ) kg/m^2, F = 49. 10, P 〈0. 01 ]. And an addictive interaction to BMI between COPD and smoking was observed (F =6. 03, P 〈 0. 05 ). BMI decreased with the increase of the stage of COPD ( F = 45.6, P 〈 0. 01 ) , with a negative relationship (r = -0. 08 ,P 〈 0. 01 ). Lower BMI was significantly associated with increased risk of COPD (X^2 = 102.68,P〈0.01). Compared with subjects with normal BMI(BMI = 24.0 -27.9 kg/m^2) , those with lower BMI ( BMI 〈 18.5 kg/m^2 ) were more likely to have COPD [ adjusted OR = 2. 12 (95% Cl 1.73 - 2.59) ], while those with higher BMI ( BMI = 24. 0 - 27.9 kg/m^2 ) and obesity ( BMI ≥ 28. 0 kg/m^2 ) were less likely to have COPD [adjusted OR =0. 67 (95% Cl 0. 59 -0.76) ;and 0.60 [ (95% Cl 0. 49-0. 73), respectively]. Moreover, there was an interaction to COPD between smoking and BMI (X^2 = 4. 73 ,P 〈 0. 05 ). Compared with COPD patients with normal BMI, the quality of life in those with lower BMI was impaired ( 55 ± 8 vs 57 ± 6 in mental scores of SF-12, F = 2. 96, P 〈 0. 05 ; 42 ± 10 vs 46 ± 9 in physical scores of SF-12, F = 4. 21 ,P 〈 0. 01 ), and their dyspnea scores were higher( 1.4± 1.5 vs 1.1 ±1.3, X^2 = 14. 32, P 〈 0. 01 ). Conclusion Lower BMI was strongly associated with COPD, possibly as a risk factor for COPD independent of smoking, and a potential predictor for COPD severity.
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2007年第1期18-22,共5页 Chinese Journal of Tuberculosis and Respiratory Diseases
基金 国家"十五"攻关课题资助项目[2001BA703B03(A)] 广东省"十五"重点支持项目(B30301)
关键词 肺疾病 慢性阻塞性 体重指数 生活质量 Pulmonary disease, chronic obstructive Body mass index Quality of life
  • 相关文献

参考文献16

  • 1周敏,徐永健.慢性阻塞性肺疾病患者的营养支持治疗及存在的问题[J].中国实用内科杂志,2005,25(2):104-106. 被引量:54
  • 2中国肥胖问题工作组数据汇总分析协作组.我国成人体重指数和腰围对相关疾病危险因素异常的预测价值:适宜体重指数和腰围切点的研究[J].中华流行病学杂志,2002,23(1):5-10. 被引量:3332
  • 3Global Initiative for Chronic Obstructive Lung Disease.Global strategy for diagnosis,management,and prevention of chronic obstructive pulmonary disease.http://www.goldcopd.org/Guidelineitem.asp? l1 = 2-12 = 1&intId = 991.(Accessed July 2006).
  • 4Zheng J,Zhong N.Normative values of pulmonary function testing in Chinese adults.Chin Med J,2002,115:50-54.
  • 5Ware J Jr,Kosinski M,Keller SD.A 12-Item Short-Form Health Survey:construction of scales and preliminary tests of reliability and validity.Med Care,1996,34:220-233.
  • 6Bostall JC,Paul EA,Garrod R,et al.Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.Thorax,1999,54:581-586.
  • 7Gray-Donald K,Gibbons L,Shapiro SH,et al.Nutritional status and mortality in chronic obstructive pulmonary disease.Am J Respir Crit Care Med,1996,153:961-966.
  • 8Schols AM,Slangen J,Volovics L,et al.Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease.Am J Respir Crit Care Med,1998,157(6 Pt 1):1791-1797.
  • 9Harik-Khan RI,Fleg JL,Wise RA.Body mass index and the risk of COPD.Chest,2002,121:370-376.
  • 10Lechner AJ.Perinatal age determines the severity of retarded lung development induced by starvation.Am Rev Respir Dis,1985,131:638-643.

二级参考文献9

  • 1张红叶,杨军,周北凡,武阳丰,李莹,陶寿淇.我国十组人群脑卒中危险因素的前瞻性研究[J].中国慢性病预防与控制,1996,4(4):150-152. 被引量:91
  • 2Brug J, Schols A, Mesters I. Dietary. change, nutrition education and chronic obstructive pulmohary disease. Patient Educ Couns, 2004, 52(3) :249-257.
  • 3Berry JK, Beum C. Rever,sal of chronic obstructive pulmonary disease-axsociated weight loss: are there pharmacological treatment options? Drugs,2004,64(10) : 1041-1052.
  • 4Cano N J, Roth H, Court-Ortune I, et al. On behalf of the Clinical Rearch Group of the SFNEP. Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilation. Eur Respir J, 2002,20 ( 1 ) : 30,37.
  • 5Ferreim IMB, Brooks D, Lacasse Y,et al. Nutritional support for individuals with COPD:a meta-analysis. Chest,2000,117(4) :672-678.
  • 6Ambrcxsino N,Clini E. Long-term mechanical ventilation and nutrition. Respir Med, 2004,98 (5) : 413-420.
  • 7Cai B, Zhu Y, Ma Y, et al. Effect of supplementing a high-fat, lowcarbohydrate enteral formula in COPD patients. Nutrition, 2003,19 (3) :229-232.
  • 8曹家琪 连志浩 等.队列(群组)研究.流行病学,第2版,第1卷[M].北京:人民卫生出版社,1995.190-206.
  • 9国家“九五”科技攻关课题协作组,武阳丰(整理),周北凡(整理),李莹(整理).我国中年人群心血管病主要危险因素流行现状及从80年代初至90年代末的变化趋势[J].中华心血管病杂志,2001,29(2):74-79. 被引量:461

共引文献3381

同被引文献752

引证文献82

二级引证文献8909

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部